Journals shouldn't accept ads: article

Share this article:
An article in PLoS Medicine called for medical journals to reject ads from drug companies, saying they compromise the objectivity of journals.

The article, co-authored by Georgetown University Medical Center professor and HRT critic Adriane Fugh-Berman, examined ads in nine medical journals, concluding they were “unreliable sources of information, since they ‘educate' physicians to prescribe the newest, most expensive drugs (which may not be superior to existing, less expensive alternatives).” Publishers could replace the lost income with consumer products advertising, the authors said. 

PLoS Medicine, a nonprofit, does not accept drug ads.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in News

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...